Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 13,815 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 13,815 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $16.89, for a total transaction of $233,335.35. Following the transaction, the chief financial officer now directly owns 1,482,595 shares in the company, valued at approximately $25,041,029.55. The trade was a 0.92 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total transaction of $3,895,000.00.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $17.18 on Friday. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $17.38. The stock has a market cap of $3.30 billion, a P/E ratio of -22.31 and a beta of 1.49. The company has a 50-day moving average price of $14.79 and a 200 day moving average price of $12.63. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently made changes to their positions in the stock. R Squared Ltd acquired a new stake in shares of Alignment Healthcare during the fourth quarter valued at about $55,000. RiverPark Advisors LLC acquired a new stake in shares of Alignment Healthcare during the fourth quarter valued at about $106,000. Tower Research Capital LLC TRC increased its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after acquiring an additional 6,286 shares during the last quarter. Ballentine Partners LLC acquired a new stake in shares of Alignment Healthcare during the fourth quarter valued at about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Alignment Healthcare during the third quarter valued at about $131,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ALHC. Barclays raised their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. Bank of America raised their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research note on Tuesday, March 4th. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Monday, February 24th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, Piper Sandler raised their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.